The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti‐cancer therapeutic agents
Abstract
Cancers have a formidable capacity to develop resistance to a large and diverse array of chemical, biologic, and physical anti‐neoplastic agents. This can be largely traced to the instability of the tumor cell genome, and the resultant ability of tumor cell populations to generate phenotypic variants rapidly. It is therefore argued that anti‐cancer strategies should be directed at eliminating those genetically stable normal diploid cells that are required for the progressive growth of tumors. Micro‐vascular endothelial cells comprising the tumor vasculature represent such a normal cell target. Moreover, specificity for tumor associated vasculature by anti‐cancer agents may be achieved by virtue of the fact that many of the endothelial cells that comprise these blood vessels are in an immature, cycling, and ‘activated’ state, in contrast to the endothelial cells associated with normal tissue and organ blood vessels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,531
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Folkman, J., & Klagsbrun, M. (1987) · Science · doi:10.1126/science.2432664 · Cited by 3,491
Transplacental Carcinogenesis by Stilbestrol
Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197108122850711 · Cited by 2,640
Cordon-Cardo, C., O'Brien, J. P., Casals, D., Rittman-Grauer, L., Biedler, J. L., Melamed, M. R., & Bertino, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.695 · Cited by 1,750
Anti-Angiogenesis: New Concept for Therapy of Solid Tumors
Folkman, J. (1972) · Annals of Surgery · doi:10.1097/00000658-197203000-00014 · Cited by 1,171
(1985) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60946-x · Cited by 1,071
TUMOR DORMANCY IN VIVO BY PREVENTION OF NEOVASCULARIZATION
Gimbrone, M. A., Leapman, S. B., Cotran, R. S., & Folkman, J. (1972) · The Journal of Experimental Medicine · doi:10.1084/jem.136.2.261 · Cited by 903
Folkman, J., Langer, R., Linhardt, R. J., Haudenschild, C., & Taylor, S. (1983) · Science · doi:10.1126/science.6192498 · Cited by 619
Mechanisms of Tumor Progression
Conti, C. J. (2010) · Comprehensive Toxicology · doi:10.1016/b978-0-08-046884-6.01417-2 · Cited by 608
Tumor interactions with the vasculature: angiogenesis and tumor metastasis
Blood, C. (1990) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(90)90014-r · Cited by 593
Protamine is an inhibitor of angiogenesis
Taylor, S., & Folkman, J. (1982) · Nature · doi:10.1038/297307a0 · Cited by 580
Endothelial proliferation in tumours and normal tissues: Continuous labelling studies
Hobson, B., & Denekamp, J. (1984) · British Journal of Cancer · doi:10.1038/bjc.1984.66 · Cited by 565
Delivery of Novel Therapeutic Agents in Tumors: Physiological Barriers and Strategies
Jain, R. K. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/81.8.570 · Cited by 557
Vascular and interstitial barriers to delivery of therapeutic agents in tumors
Jain, R. K. (1990) · CANCER AND METASTASIS REVIEW · doi:10.1007/bf00046364 · Cited by 489
A New Class of Steroids Inhibits Angiogenesis in the Presence of Heparin or a Heparin Fragment
Crum, R., Szabo, S., & Folkman, J. (1985) · Science · doi:10.1126/science.2416056 · Cited by 488
Identification of an Inhibitor of Neovascularization from Cartilage
Moses, M. A., Sudhalter, J., & Langer, R. (1990) · Science · doi:10.1126/science.1694043 · Cited by 477
Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene
Rastinejad, F., Polverini, P. J., & Bouck, N. P. (1989) · Cell · doi:10.1016/0092-8674(89)90238-9 · Cited by 463
Bailar, J. C., & Smith, E. M. (1986) · New England Journal of Medicine · doi:10.1056/nejm198605083141905 · Cited by 409
Farber, E. (1984) · PubMed · Cited by 353
The developmental biology of primary human malignant melanomas.
Clark, W. H., Am, A., Ea, B., Ch, Y., Cm, M., & Rj, R. (1975) · PubMed · Cited by 334
Gene Amplification and Drug Resistance in Cultured Murine Cells
Schimke, R. T., Kaufman, R. J., Alt, F. W., & Kellems, R. F. (1978) · Science · doi:10.1126/science.715457 · Cited by 314
Control of Angiogenesis with Synthetic Heparin Substitutes
Folkman, J., Weisz, P. B., Joullié, M. M., Li, W. W., & Ewing, W. R. (1989) · Science · doi:10.1126/science.2467380 · Cited by 289
Angiostatic Steroids: Method of Discovery and Mechanism of Action
FOLKMAN, J., & INGBER, D. E. (1987) · Annals of Surgery · doi:10.1097/00000658-198709000-00016 · Cited by 266
Vascular attack as a therapeutic strategy for cancer
Denekamp, J. (1990) · CANCER AND METASTASIS REVIEW · doi:10.1007/bf00046365 · Cited by 264
Becker, D., Meier, C. B., & Herlyn, M. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08543.x · Cited by 263
Endothelial cell proliferation as a novel approach to targeting tumour therapy
Denekamp, J. (1982) · British Journal of Cancer · doi:10.1038/bjc.1982.16 · Cited by 249
Biology of tumor progression in human melanocytes.
Herlyn, M., Clark, W. H., Rodeck, U., Mancianti, M., Jambrosic, J., & Koprowski, H. (1987) · PubMed · Cited by 236
The direct activation of human multidrug resistance gene (MDR1) by anticancer agents
Kohno, K., Sato, S.-I., Takano, H., Matsuo, K.-I., & Kuwano, M. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92761-7 · Cited by 216
INGBER, D. E., MADRI, J. A., & FOLKMAN, J. (1986) · Endocrinology · doi:10.1210/endo-119-4-1768 · Cited by 211
Microvascular Injury in Pathogenesis of Interferon-Induced Necrosis of Subcutaneous Tumors in Mice
Dvorak, H. F., & Gresser, I. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.7.497 · Cited by 192
Toward an Understanding of Angiogenesis: Search and Discovery
Folkman, J. (1985) · Perspectives in Biology and Medicine · doi:10.1353/pbm.1985.0049 · Cited by 184
Growth Dominance of the Metastatic Cancer Cell: Cellular and Molecular Aspects
(1990) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60469-8 · Cited by 178
Terrier, P., Townsend, A. J., Coindre, J., Triche, T. J., & Cowan, K. H. (1990) · Europe PMC (PubMed Central) · Cited by 162
Control of tumor growth in animals by infusion of an angiogenesis inhibitor.
Langer, R., Conn, H., Vacanti, J. P., Haudenschild, C. C., & Folkman, J. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.4331 · Cited by 150
Tumor angiogenesis: the role of oncogenes and tumor suppressor genes.
BOUCK, N. P. (1990) · PubMed · Cited by 136
Folkman, J. (1990) · Cancer and Metastasis Reviews · doi:10.1007/bf00046358 · Cited by 124
Mechanisms of Multidrug Resistance
Kellen, J. A. (1995) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4615-9852-7_1 · Cited by 117
Schlaifer, D., Laurent, G., Chittal, S. M., TSURUO, T., Souès, S., Muller, C., Charcosset, J., Alard, C., Brousset, P., & Mazerrolles, C. (1990) · British Journal of Cancer · doi:10.1038/bjc.1990.256 · Cited by 95
Inhibition of in vitro angiogenesis by lymphotoxin and interferon-γ
Tsuruoka, N., Sugiyama, M., Tawaragi, Y., Tsujimoto, M., Nishihara, T., Goto, T., & Sato, N. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81104-5 · Cited by 80
Hagemeier, H.-H., Vollmer, E., Goerdt, S., Schulze‐Osthoff, K., & Sorg, C. (1986) · International Journal of Cancer · doi:10.1002/ijc.2910380405 · Cited by 67
Gerlach, H., Lieberman, H. B., Bach, R. R., Godman, G. C., Brett, J., & Stern, D. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.170.3.913 · Cited by 66
What is the role of angiogenesis in metastasis from cutaneous melanoma?
Folkman, J. (1987) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(87)90370-1 · Cited by 64
Unbalanced transmethylation and the perturbation of the differentiated state leading to cancer
Hoffman, R. M. (1990) · BioEssays · doi:10.1002/bies.950120404 · Cited by 29
Cited by
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Modes of resistance to anti-angiogenic therapy
Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2442 · Cited by 2,953
Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
Boehm, T., Folkman, J., Browder, T., & O'Reilly, M. S. (1997) · Nature · doi:10.1038/37126 · Cited by 1,683
Tumor Induction of VEGF Promoter Activity in Stromal Cells
Fukumura, D., Xavier, R., Sugiura, T., Chen, Y., Park, E.-C., Lu, N., Selig, M., Nielsen, G., Taksir, T., Jain, R. K., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81731-6 · Cited by 996
Margolin, K., Gordon, M. S., Holmgren, E., Gaudreault, J., Novotny, W., Fyfe, G., Adelman, D., Stalter, S., & Breed, J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.3.851 · Cited by 364
Metadata
- Authors
- Kerbel, R. S.
- Venue
- BioEssays
- Publisher
- Wiley
- Published
- 1991-01
- Volume
- 13
- Issue
- 1
- Pages
- 31-36
- ISSN
- 0265-9247 (ISSN-L)
- 1521-1878
- OpenAlex
- W2155056678
- Cited by
- 441
- References
- 47
- FWCI
- 0.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.